Morgan Stanley Novo Nordisk A S Transaction History
Morgan Stanley
- $1.23 Trillion
- Q1 2024
A detailed history of Morgan Stanley transactions in Novo Nordisk A S stock. As of the latest transaction made, Morgan Stanley holds 12,011,853 shares of NVO stock, worth $1.71 Billion. This represents 0.13% of its overall portfolio holdings.
Number of Shares
12,011,853
Previous 10,614,811
13.16%
Holding current value
$1.71 Billion
Previous $1.1 Billion
40.45%
% of portfolio
0.13%
Previous 0.1%
Shares
13 transactions
Others Institutions Holding NVO
# of Institutions
1,854Shares Held
309MCall Options Held
5.29MPut Options Held
4.93M-
Jennison Associates LLC21.1MShares$3.01 Billion1.82% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.7MShares$1.96 Billion0.83% of portfolio
-
Bank Of America Corp Charlotte, NC13.1MShares$1.86 Billion0.16% of portfolio
-
Fayez Sarofim & CO Houston, TX11.8MShares$1.69 Billion4.6% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny10.8MShares$1.54 Billion2.18% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $322B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...